"We're focused on whether C3.ai's public statements were misleading in their failure to fully disclose how CEO Thomas M. Siebel's health was affecting the company's ability to close deals and meet financial targets," said Reed Kathrein, the Hagens Berman partner leading the investigation. Accessibility StatementSkip Navigation SAN FRANCISCO, Sept. 9, 2025 /PRNewswire/ -- A new class action lawsuit is targeting enterprise AI software company C3.ai (NYSE: AI) and its senior leadership, alleging they misled in ...